The Asia Pacific large-joint reconstructive implant market has experienced limited growth in the initial years due to COVID-19 considering many hip and knee implant procedures are considered…
The biosurgical agent market in Latin America will observe modest growth through 2032, primarily driven by surgical procedure volume growth, increasing evidence of the clinical benefits of…
The US PACS, RIS, and CVIS market is projected to experience modest expansion through 2033. This growth is driven by the increasing rates of chronic illnesses in the US that drive radiology and…
The US foot and ankle orthopedic device market is supported by sustained growth in high-volume segments in recent years. This is accompanied by rapid implant innovation in implant, instrumentation…
The European large-joint reconstructive implant market is poised for long-term expansion, driven by the adoption of innovative technologies like patient-conforming and 3-D printed implants, smart…
The US biopsy device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent slow growth…
The Latin American heart valve device market will be driven by expanding patient pool and availability of several new THV devices. Rapid adoption of these devices and positive results from…
The biosurgical agent market in Europe will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…
The European PACS, RIS, and CVIS market will continue to expand through 2032, despite the short-term negative impact of the COVID-19 pandemic, driven by Europe’s increasingly aging population,…
Over the forecast period, Latin American spinal implant market expansion will be driven by procedure volume growth due to an aging population and uptake of premium innovations such as 3-D–printed…
The biosurgical agent market in Latin America will observe modest growth through 2032, primarily driven by surgical procedure volume growth, increasing evidence of the clinical benefits of…
The Japanese biosurgical agent market will exhibit moderate growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in…
Following the recovery from the impact of the COVID-19 pandemic, the US diagnostic imaging equipment servicing market will see marginal growth through 2032. The market growth will primarily be…
The European market for breast implants and reconstruction devices will exhibit modest growth, driven by several key factors. The safety and aesthetic results of breast augmentation and…
The Latin American EP mapping and ablation device market will experience strong growth as a result of favorable demographic trends, increasing ablation procedure volumes and the introduction of…